Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayla A Holder

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Cellular and Infection Microbiology|May 21, 2020
TIGIT Blockade: A Multipronged Approach to Target the HIV ReservoirKayla A Holder, Michael D Grant
Journal of Leukocyte Biology|April 10, 2019
Human cytomegalovirus IL-10 augments NK cell cytotoxicityKayla A Holder, Michael D Grant
AIDS Research and Therapy|September 13, 2017
Modulation of the strength and character of HIV-specific CD8<sup>+</sup> T cell responses with heteroclitic peptidesKayla A Holder, Michael D Grant
Frontiers in Immunology|November 29, 2018
Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus InfectionKayla A Holder, Julie Lajoie, Michael D Grant
Clinical & Translational Immunology|October 28, 2021
TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4<sup>+</sup> T cellsKayla A Holder, Kimberley Burt, Michael D Grant
Immunology|January 23, 2018
Origins of natural killer cell memory: special creation or adaptive evolutionKayla A Holder, Emilie M Comeau, Michael D Grant
Biomed Research International|July 25, 2014
Natural killer cell function and dysfunction in hepatitis C virus infectionKayla A Holder, Rodney S Russell, Michael D Grant
Pathogens (Basel, Switzerland)|January 8, 2025
Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves TrogocytosisNazanin Ghasemi, Kayla A Holder, Danielle P Ings, et al.
Viruses|March 13, 2019
Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C<sup>null</sup> Human Immunodeficiency Virus-Infected IndividualsEmilie M Comeau, Kayla A Holder, Neva J Fudge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2013
Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functionsKayla A Holder, Staci N Stapleton, Maureen E Gallant, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Cellular and Infection Microbiology|May 21, 2020
TIGIT Blockade: A Multipronged Approach to Target the HIV ReservoirKayla A Holder, Michael D Grant
Journal of Leukocyte Biology|April 10, 2019
Human cytomegalovirus IL-10 augments NK cell cytotoxicityKayla A Holder, Michael D Grant
AIDS Research and Therapy|September 13, 2017
Modulation of the strength and character of HIV-specific CD8<sup>+</sup> T cell responses with heteroclitic peptidesKayla A Holder, Michael D Grant
Frontiers in Immunology|November 29, 2018
Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus InfectionKayla A Holder, Julie Lajoie, Michael D Grant
Clinical & Translational Immunology|October 28, 2021
TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4<sup>+</sup> T cellsKayla A Holder, Kimberley Burt, Michael D Grant
Immunology|January 23, 2018
Origins of natural killer cell memory: special creation or adaptive evolutionKayla A Holder, Emilie M Comeau, Michael D Grant
Biomed Research International|July 25, 2014
Natural killer cell function and dysfunction in hepatitis C virus infectionKayla A Holder, Rodney S Russell, Michael D Grant
Pathogens (Basel, Switzerland)|January 8, 2025
Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves TrogocytosisNazanin Ghasemi, Kayla A Holder, Danielle P Ings, et al.
Viruses|March 13, 2019
Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C<sup>null</sup> Human Immunodeficiency Virus-Infected IndividualsEmilie M Comeau, Kayla A Holder, Neva J Fudge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2013
Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functionsKayla A Holder, Staci N Stapleton, Maureen E Gallant, et al.
Pageof 2